Literature DB >> 34039637

Context-Dependent miR-21 Regulation of TLR7-Mediated Autoimmune and Foreign Antigen-Driven Antibody-Forming Cell and Germinal Center Responses.

Stephanie L Schell1, Kristen N Bricker1, Adam J Fike1, Sathi Babu Chodisetti1, Phillip P Domeier2, Nicholas M Choi1, Melinda J Fasnacht1, Sara A Luckenbill1, Steven F Ziegler2, Ziaur S M Rahman3.   

Abstract

MicroRNAs (miRNAs) are involved in healthy B cell responses and the loss of tolerance in systemic lupus erythematosus (SLE), although the role of many miRNAs remains poorly understood. Dampening miR-21 activity was previously shown to reduce splenomegaly and blood urea nitrogen levels in SLE-prone mice, but the detailed cellular responses and mechanism of action remains unexplored. In this study, using the TLR7 agonist, imiquimod-induced SLE model, we observed that loss of miR-21 in Sle1b mice prevented the formation of plasma cells and autoantibody-producing Ab-forming cells (AFCs) without a significant effect on the magnitude of the germinal center (GC) response. We further observed reduced dendritic cell and monocyte numbers in the spleens of miR-21-deficient Sle1b mice that were associated with reduced IFN, proinflammatory cytokines, and effector CD4+ T cell responses. RNA sequencing analysis on B cells from miR-21-deficient Sle1b mice revealed reduced activation and response to IFN, and cytokine and target array analysis revealed modulation of numerous miR-21 target genes in response to TLR7 activation and type I IFN stimulation. Our findings in the B6.Sle1bYaa (Sle1b Yaa) spontaneous model recapitulated the miR-21 role in TLR7-induced responses with an additional role in autoimmune GC and T follicular helper responses. Finally, immunization with T-dependent Ag revealed a role for miR-21 in foreign Ag-driven GC and Ab, but not AFC, responses. Our data suggest a potential multifaceted, context-dependent role for miR-21 in autoimmune and foreign Ag-driven AFC and GC responses. Further study is warranted to delineate the cell-intrinsic requirements and mechanisms of miR-21 during infection and SLE development.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34039637      PMCID: PMC8617059          DOI: 10.4049/jimmunol.2001039

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

Review 2.  Mechanisms of Tissue Injury in Lupus Nephritis.

Authors:  Giovanna Flores-Mendoza; Stephanie P Sansón; Santiago Rodríguez-Castro; José C Crispín; Florencia Rosetti
Journal:  Trends Mol Med       Date:  2018-03-08       Impact factor: 11.951

3.  Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation.

Authors:  Shaun W Jackson; Nicole E Scharping; Nikita S Kolhatkar; Socheath Khim; Marc A Schwartz; Quan-Zhen Li; Kelly L Hudkins; Charles E Alpers; Denny Liggitt; David J Rawlings
Journal:  J Immunol       Date:  2014-04-07       Impact factor: 5.422

4.  MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity.

Authors:  Thomas X Lu; Jochen Hartner; Eun-Jin Lim; Victoria Fabry; Melissa K Mingler; Eric T Cole; Stuart H Orkin; Bruce J Aronow; Marc E Rothenberg
Journal:  J Immunol       Date:  2011-08-17       Impact factor: 5.422

Review 5.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

Authors:  Rajesha Rupaimoole; Frank J Slack
Journal:  Nat Rev Drug Discov       Date:  2017-02-17       Impact factor: 84.694

6.  The Lupus Susceptibility Gene Pbx1 Regulates the Balance between Follicular Helper T Cell and Regulatory T Cell Differentiation.

Authors:  Seung-Chul Choi; Tarun E Hutchinson; Anton A Titov; Howard R Seay; Shiwu Li; Todd M Brusko; Byron P Croker; Shahram Salek-Ardakani; Laurence Morel
Journal:  J Immunol       Date:  2016-06-13       Impact factor: 5.422

7.  MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice.

Authors:  Yang Pan; Tingting Jia; Yuan Zhang; Kuo Zhang; Rui Zhang; Jinming Li; Lunan Wang
Journal:  Int J Nanomedicine       Date:  2012-12-03

8.  IgG2a restriction of murine antibodies elicited by viral infections.

Authors:  J P Coutelier; J T van der Logt; F W Heessen; G Warnier; J Van Snick
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

9.  MicroRNAs of the miR-17∼92 family are critical regulators of T(FH) differentiation.

Authors:  Seung Goo Kang; Wen-Hsien Liu; Peiwen Lu; Hyun Yong Jin; Hyung W Lim; Jovan Shepherd; Daniel Fremgen; Eric Verdin; Michael B A Oldstone; Hai Qi; John R Teijaro; Changchun Xiao
Journal:  Nat Immunol       Date:  2013-06-30       Impact factor: 25.606

10.  The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity.

Authors:  David Medgyesi; Elias Hobeika; Robert Biesen; Florian Kollert; Adriano Taddeo; Reinhard E Voll; Falk Hiepe; Michael Reth
Journal:  J Exp Med       Date:  2014-03-03       Impact factor: 14.307

View more
  3 in total

1.  Labile iron accumulation augments T follicular helper cell differentiation.

Authors:  Yogesh Scindia; Borna Mehrad; Laurence Morel
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

Review 2.  miRNA-Mediated Control of B Cell Responses in Immunity and SLE.

Authors:  Stephanie L Schell; Ziaur S M Rahman
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 3.  Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives.

Authors:  Mara Fernandes; Herlander Marques; Ana Luísa Teixeira; Rui Medeiros
Journal:  Biomedicines       Date:  2021-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.